248 related articles for article (PubMed ID: 15180664)
1. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test.
Dendukuri N; Rahme E; Bélisle P; Joseph L
Biometrics; 2004 Jun; 60(2):388-97. PubMed ID: 15180664
[TBL] [Abstract][Full Text] [Related]
2. Bayesian sample size for diagnostic test studies in the absence of a gold standard: Comparing identifiable with non-identifiable models.
Dendukuri N; Bélisle P; Joseph L
Stat Med; 2010 Nov; 29(26):2688-97. PubMed ID: 20803558
[TBL] [Abstract][Full Text] [Related]
3. A general approach to sample size determination for prevalence surveys that use dual test protocols.
Cheng D; Stamey JD; Branscum AJ
Biom J; 2007 Aug; 49(5):694-706. PubMed ID: 17722203
[TBL] [Abstract][Full Text] [Related]
4. Bayesian sample-size determination for inference on two binomial populations with no gold standard classifier.
Stamey JD; Seaman JW; Young DM
Stat Med; 2005 Oct; 24(19):2963-76. PubMed ID: 16007574
[TBL] [Abstract][Full Text] [Related]
5. The utility of prior information and stratification for parameter estimation with two screening tests but no gold standard.
Gustafson P
Stat Med; 2005 Apr; 24(8):1203-17. PubMed ID: 15558709
[TBL] [Abstract][Full Text] [Related]
6. Estimating disease prevalence in the absence of a gold standard.
Black MA; Craig BA
Stat Med; 2002 Sep; 21(18):2653-69. PubMed ID: 12228883
[TBL] [Abstract][Full Text] [Related]
7. On the interpretation of test sensitivity in the two-test two-population problem: assumptions matter.
Johnson WO; Gardner IA; Metoyer CN; Branscum AJ
Prev Vet Med; 2009 Oct; 91(2-4):116-21. PubMed ID: 19651450
[TBL] [Abstract][Full Text] [Related]
8. Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections.
Martin DH; Nsuami M; Schachter J; Hook EW; Ferrero D; Quinn TC; Gaydos C
J Clin Microbiol; 2004 Oct; 42(10):4749-58. PubMed ID: 15472336
[TBL] [Abstract][Full Text] [Related]
9. Bayesian modelling of imperfect ascertainment methods in cancer studies.
Bernatsky S; Joseph L; Bélisle P; Boivin JF; Rajan R; Moore A; Clarke A
Stat Med; 2005 Aug; 24(15):2365-79. PubMed ID: 15977290
[TBL] [Abstract][Full Text] [Related]
10. Estimating disease prevalence in a Bayesian framework using probabilistic constraints.
Berkvens D; Speybroeck N; Praet N; Adel A; Lesaffre E
Epidemiology; 2006 Mar; 17(2):145-53. PubMed ID: 16477254
[TBL] [Abstract][Full Text] [Related]
11. Bayesian latent class models with conditionally dependent diagnostic tests: a case study.
Menten J; Boelaert M; Lesaffre E
Stat Med; 2008 Sep; 27(22):4469-88. PubMed ID: 18551515
[TBL] [Abstract][Full Text] [Related]
12. Sample size determination for estimation of the accuracy of two conditionally independent tests in the absence of a gold standard.
Georgiadis MP; Johnson WO; Gardner IA
Prev Vet Med; 2005 Sep; 71(1-2):1-10. PubMed ID: 16076507
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic test accuracy and prevalence inferences based on joint and sequential testing with finite population sampling.
Su CL; Gardner IA; Johnson WO
Stat Med; 2004 Jul; 23(14):2237-55. PubMed ID: 15236428
[TBL] [Abstract][Full Text] [Related]
14. Sample size calculation should be performed for design accuracy in diagnostic test studies.
Flahault A; Cadilhac M; Thomas G
J Clin Epidemiol; 2005 Aug; 58(8):859-62. PubMed ID: 16018921
[TBL] [Abstract][Full Text] [Related]
15. Modeling conditional dependence between diagnostic tests: a multiple latent variable model.
Dendukuri N; Hadgu A; Wang L
Stat Med; 2009 Feb; 28(3):441-61. PubMed ID: 19067379
[TBL] [Abstract][Full Text] [Related]
16. Some issues in resolution of diagnostic tests using an imperfect gold standard.
Hawkins DM; Garrett JA; Stephenson B
Stat Med; 2001 Jul; 20(13):1987-2001. PubMed ID: 11427955
[TBL] [Abstract][Full Text] [Related]
17. On sample size for sensitivity and specificity in prospective diagnostic accuracy studies.
Li J; Fine J
Stat Med; 2004 Aug; 23(16):2537-50. PubMed ID: 15287083
[TBL] [Abstract][Full Text] [Related]
18. The choice of sample size: a mixed Bayesian / frequentist approach.
Pezeshk H; Nematollahi N; Maroufy V; Gittins J
Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis.
Dorny P; Phiri IK; Vercruysse J; Gabriel S; Willingham AL; Brandt J; Victor B; Speybroeck N; Berkvens D
Int J Parasitol; 2004 Apr; 34(5):569-76. PubMed ID: 15064121
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of diagnostic accuracy studies accounting for disease prevalence: alternative parameterizations and model selection.
Chu H; Nie L; Cole SR; Poole C
Stat Med; 2009 Aug; 28(18):2384-99. PubMed ID: 19499551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
